Join the DDA or

Diltiazem HCl 2% cream recall

Consistency problems

July 20th 2023

Tagged: MHRA alert

By Ailsa Colquhoun

Quantum Pharmaceutical is recalling three batches of diltiazem HCl 2% cream [unlicensed medicine]

The affected batches are:

Product nameBatch numberExpiry datePack sizeDate first distributed
Diltiazem HCl 2% Cream [unlicensed medicine]M140249720 Sep 202330g22 Jun 2023
Diltiazem HCl 2% Cream [unlicensed medicine]M140257421 Sep 202330g27 Jun 2023
Diltiazem HCl 2% Cream [unlicensed medicine]M140268024 Sep 202330g07 Jul 2023

Affected products have a reduced viscosity and more closely resemble a lotion than a cream. These batches are being recalled as a precautionary measure.

Dispensaries are asked to quarantine all remaining stock and liaise with Quantum Pharmaceutical on the return process.

Patients using this product may experience issues with the application of the cream due to its consistency. However, this does not appear to have affected the product’s efficacy or pose a risk to patient safety. Affected patients should contact their dispenser for a replacement.

For medical information enquiries, email: [email protected]